BACKGROUND: Donors with characteristics that may increase the likelihood of disease transmission with transplantation are noted as increased risk via Public Health Service criteria. This study aimed to establish the implications of declining an increased-risk donor (IRD) organ offer in lung transplantation. METHODS: Adult candidates waitlisted for isolated lung transplantation in the United States using the Organ Procurement and Transplantation Network /United Network of Organ Sharing registry from 2007 to 2017 were identified. Individual match run files identified candidate recipients who matched to an IRD offer. Competing-risks analysis ascertained the likelihood of survival to transplantation. A stratified Cox model and restricted mean survival times estimated the survival benefit associated with the acceptance of an IRD organ. RESULTS: A total of 6,963 candidates met inclusion criteria, and 1,473 (21.2%) accepted an IRD offer. Candidates who accepted an IRD offer were older, more likely to be male, and had a higher lung allocation score at the time of listing (all p < 0.05). At 1 year after an IRD offer decline, 70.5% of candidates underwent a lung transplant, 13.8% died or decompensated, and 14.9% were still awaiting transplant. Compared with those who declined, candidates who accepted the IRD offer had significantly improved cumulative mortality at 1 year (14.1% vs 23.9%, p < 0.001) and 5 years (48.4% vs 53.8%, p < 0.001). CONCLUSIONS: IRD organ declination is associated with a decreased rate of lung transplantation and worse survival. Overall post-transplant survival rates for those who survive to transplantation are equivalent.
BACKGROUND: Donors with characteristics that may increase the likelihood of disease transmission with transplantation are noted as increased risk via Public Health Service criteria. This study aimed to establish the implications of declining an increased-risk donor (IRD) organ offer in lung transplantation. METHODS: Adult candidates waitlisted for isolated lung transplantation in the United States using the Organ Procurement and Transplantation Network /United Network of Organ Sharing registry from 2007 to 2017 were identified. Individual match run files identified candidate recipients who matched to an IRD offer. Competing-risks analysis ascertained the likelihood of survival to transplantation. A stratified Cox model and restricted mean survival times estimated the survival benefit associated with the acceptance of an IRD organ. RESULTS: A total of 6,963 candidates met inclusion criteria, and 1,473 (21.2%) accepted an IRD offer. Candidates who accepted an IRD offer were older, more likely to be male, and had a higher lung allocation score at the time of listing (all p < 0.05). At 1 year after an IRD offer decline, 70.5% of candidates underwent a lung transplant, 13.8% died or decompensated, and 14.9% were still awaiting transplant. Compared with those who declined, candidates who accepted the IRD offer had significantly improved cumulative mortality at 1 year (14.1% vs 23.9%, p < 0.001) and 5 years (48.4% vs 53.8%, p < 0.001). CONCLUSIONS:IRD organ declination is associated with a decreased rate of lung transplantation and worse survival. Overall post-transplant survival rates for those who survive to transplantation are equivalent.
Authors: Luke J Benvenuto; David R Anderson; Hanyoung P Kim; Jaime L Hook; Lori Shah; Hilary Y Robbins; Frank D'Ovidio; Matthew Bacchetta; Joshua R Sonett; Selim M Arcasoy Journal: Am J Transplant Date: 2018-01-27 Impact factor: 8.086
Authors: E K H Chow; A B Massie; A D Muzaale; A L Singer; L M Kucirka; R A Montgomery; H P Lehmann; D L Segev Journal: Am J Transplant Date: 2013-05 Impact factor: 8.086
Authors: L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev Journal: Am J Transplant Date: 2011-03-14 Impact factor: 8.086
Authors: Mary G Bowring; Courtenay M Holscher; Sheng Zhou; Allan B Massie; Jacqueline Garonzik-Wang; Lauren M Kucirka; Sommer E Gentry; Dorry L Segev Journal: Am J Transplant Date: 2017-12-05 Impact factor: 8.086
Authors: Michael S Mulvihill; Hui J Lee; Jeremy Weber; Ashley Y Choi; Morgan L Cox; Babatunde A Yerokun; Muath A Bishawi; Jacob Klapper; Maragatha Kuchibhatla; Matthew G Hartwig Journal: J Heart Lung Transplant Date: 2020-01-21 Impact factor: 10.247
Authors: Samantha E Halpern; Alec McConnell; Sarah B Peskoe; Vignesh Raman; Oliver K Jawitz; Ashley Y Choi; Megan L Neely; Scott M Palmer; Matthew G Hartwig Journal: Am J Transplant Date: 2020-10-29 Impact factor: 8.086
Authors: Samantha E Halpern; Oliver K Jawitz; Vignesh Raman; Ashley Y Choi; John C Haney; Jacob A Klapper; Matthew G Hartwig Journal: Clin Transplant Date: 2021-07-14 Impact factor: 3.456